BREAKING
Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 20 minutes ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 4 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 6 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 7 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 8 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 8 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 11 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 11 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 12 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 20 minutes ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 4 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 6 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 7 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 8 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 8 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 11 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 11 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 12 hours ago
ADVERTISEMENT
Market News

ExxonMobil (XOM) slips to a loss in Q1 but beats estimates

ExxonMobil (NYSE: XOM) reported its financial results for the quarter ended March 31, 2020, on Friday. Despite the impact of the COVID-19 pandemic on the global markets, the results exceeded analysts’ expectations. ExxonMobil slipped to a loss in the first quarter of 2020 from a profit last year due to the inclusion of a charge […]

$XOM May 1, 2020 1 min read

ExxonMobil (NYSE: XOM) reported its financial results for the quarter ended March 31, 2020, on Friday. Despite the impact of the COVID-19 pandemic on the global markets, the results exceeded analysts’ expectations.

ExxonMobil slipped to a loss in the first quarter of 2020 from a profit last year due to the inclusion of a charge from market-related write-downs. This reflected non-cash inventory valuation impacts from lower commodity prices and asset impairments.

ExxonMobil (XOM) Q1 2020 earnings review

The company said the COVID-19 has significantly impacted near-term demand, resulting in oversupplied markets and unprecedented pressure on commodity prices and margins. ExxonMobil’s capital allocation priorities remain unchanged. The company’s objective is to continue investing in industry-advantaged projects to create value, preserve cash for the dividend, and make appropriate use of its balance sheet.

In response to market conditions, ExxonMobil is lowering 2020 capital spending by 30% and cash operating expenses by 15%. Capex is now expected to be about $23 billion for the year, down from the previously announced guidance of $33 billion.

ADVERTISEMENT

Past Performance

ADVERTISEMENT